Viewing Study NCT06419205


Ignite Creation Date: 2025-12-25 @ 3:29 AM
Ignite Modification Date: 2026-05-25 @ 1:06 AM
Study NCT ID: NCT06419205
Status: WITHDRAWN
Last Update Posted: 2025-04-20
First Post: 2024-05-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
Sponsor: Q32 Bio Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None IgA Nephropathy View
None Lupus Nephritis (LN) View
None C3 (Complement Component 3) Glomerulopathy View
Keywords: